Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Surrozen (SRZNW) Research & Development (2023 - 2025)

Historic Research & Development for Surrozen (SRZNW) over the last 3 years, with Q3 2025 value amounting to $7.8 million.

  • Surrozen's Research & Development rose 4950.0% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.7 million, marking a year-over-year increase of 1758.47%. This contributed to the annual value of $21.1 million for FY2024, which is 2239.44% down from last year.
  • Per Surrozen's latest filing, its Research & Development stood at $7.8 million for Q3 2025, which was up 4950.0% from $6.0 million recorded in Q2 2025.
  • Surrozen's 5-year Research & Development high stood at $7.8 million for Q3 2025, and its period low was $5.2 million during Q3 2024.
  • For the 3-year period, Surrozen's Research & Development averaged around $6.0 million, with its median value being $6.0 million (2025).
  • Its Research & Development has fluctuated over the past 5 years, first crashed by 1492.15% in 2024, then soared by 4950.0% in 2025.
  • Surrozen's Research & Development (Quarter) stood at $6.1 million in 2023, then decreased by 12.22% to $5.4 million in 2024, then surged by 45.31% to $7.8 million in 2025.
  • Its Research & Development was $7.8 million in Q3 2025, compared to $6.0 million in Q2 2025 and $6.6 million in Q1 2025.